Nanomedicine-Challenge and Perspectives

被引:986
作者
Riehemann, Kristina [1 ,2 ]
Schneider, Stefan W. [3 ]
Luger, Thomas A. [4 ]
Godin, Biana [5 ]
Ferrari, Mauro [5 ]
Fuchs, Harald [1 ,2 ]
机构
[1] Univ Munster, Ctr Nanotechnol, D-48149 Munster, Germany
[2] Univ Munster, Inst Phys, D-48149 Munster, Germany
[3] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, D-68135 Mannheim, Germany
[4] Klin & Polyklin Hautkrankheiten, D-48149 Munster, Germany
[5] Univ Texas Hlth Sci Ctr Houston, Dept Biomed Engn, Div Nanomed, Houston, TX 77030 USA
关键词
nanoprobes; nanotechnology; personalized medicine; theranostics; PEGYLATED LIPOSOMAL DOXORUBICIN; ACCELERATED BLOOD CLEARANCE; DIGITAL HOLOGRAPHIC MICROSCOPY; ALBUMIN-BOUND PACLITAXEL; IN-VIVO; DRUG-DELIVERY; ANTIBODY ARRAYS; MASS-SPECTROMETRY; MAGNETIC NANOPARTICLES; NANOCRYSTALLINE SILVER;
D O I
10.1002/anie.200802585
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The application of nanotechnology concepts to medicine joins two large cross-disciplinary fields with an unprecedented societal and economical potential arising from the natural combination of specific achievements in the respective fields. The common basis evolves from the molecular-scale properties relevant to the two fields. Local probes and molecular imaging techniques allow surface and interface properties to be characterized on a nanometer scale at predefined locations, while chemical approaches offer the opportunity to elaborate and address surfaces, for example, for targeted drug delivery, enhanced biocompatibility, and neuroprosthetic purposes. However, concerns arise in this cross-disciplinary area about toxicological aspects and ethical implications. This Review gives an overview of selected recent developments and applications of nanomedicine. © 2009 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:872 / 897
页数:26
相关论文
共 305 条
[21]   Recent developments in urologic oncology: positron emission tomography molecular imaging [J].
Bouchelouche, Kirsten ;
Oehr, Peter .
CURRENT OPINION IN ONCOLOGY, 2008, 20 (03) :321-326
[22]   Analysis of lung surfactant model systems with time-of-flight secondary ion mass spectrometry [J].
Bourdos, N ;
Kollmer, F ;
Benninghoven, A ;
Ross, M ;
Sieber, M ;
Galla, HJ .
BIOPHYSICAL JOURNAL, 2000, 79 (01) :357-369
[23]   Nanoparticle and targeted systems for cancer therapy [J].
Brannon-Peppas, L ;
Blanchette, JO .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (11) :1649-1659
[24]   Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components [J].
Brown, DM ;
Stone, V ;
Findlay, P ;
MacNee, W ;
Donaldson, K .
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2000, 57 (10) :685-691
[25]   Semiconductor nanocrystals as fluorescent biological labels [J].
Bruchez, M ;
Moronne, M ;
Gin, P ;
Weiss, S ;
Alivisatos, AP .
SCIENCE, 1998, 281 (5385) :2013-2016
[26]   Multicomponent submicron features of biomolecules created by voltage controlled deposition from a nanopipet [J].
Bruckbauer, A ;
Zhou, DJ ;
Ying, LM ;
Korchev, YE ;
Abell, C ;
Klenerman, D .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (32) :9834-9839
[27]   Effective methods to correct contrast agent-induced errors in PET quantification in cardiac PET/CT [J].
Buether, Florian ;
Stegger, Lars ;
Dawood, Mohammad ;
Range, Felix ;
Schaefers, Michael ;
Fischbach, Roman ;
Wichter, Thomas ;
Schober, Otmar ;
Schaefers, Klaus P. .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (07) :1060-1068
[28]   SPR microscopy and its applications to high-throughput analyses of biomolecular binding events and their kinetics [J].
Campbell, Charles T. ;
Kim, Gibum .
BIOMATERIALS, 2007, 28 (15) :2380-2392
[29]   Porous silicon as a therapeutic biomaterial [J].
Canham, L .
1ST ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS, 2000, :109-112
[30]   Amorphous hydrocarbon based thin films for high-aspect-ratio MEMS applications [J].
Cao, DM ;
Wang, T ;
Feng, B ;
Meng, WJ ;
Kelly, KW .
THIN SOLID FILMS, 2001, 398 :553-559